THE OFFICIAL NEWS SOURCE OF ACR CONVERGENCE 2022 • NOVEMBER 10-14



Putting the Puzzle Together in Axial Disease

AOSD Unveiled: Connecting the Dots on the Spectrum of Still’s Disease

Friday, November 6, 2020 | 6:00-8:00 PM ET
Developed and offered by Novartis Medical Affairs

VISIT EVENT NOW

Session Description:
Can you put the puzzle together in axial spondyloarthritis (axSpA) and axial psoriatic arthritis (axPsA)? Axial involvement is an important feature in patients with SpA and PsA, and this manifestation has various similarities and differences between both diseases.1,2 Recognizing and assessing the unique presentation of axPsA and axSpA is critical to improve the outcomes in our patients.

Is it time to connect the dots between systemic juvenile idiopathic arthritis (SJIA) and adult-onset Still’s disease (AOSD)? There is a growing recognition that SJIA and AOSD represent the same disease continuum with different ages of onset.3 Both conditions are rare autoinflammatory disorders of unknown etiology.3 In addition to Still’s disease rarity, patients present with varying symptoms and are diagnosed by exclusion of other diseases, which may result in a long time to proper care.4,5 A delay in diagnosis and failure to control disease activity can lead to severe and life-threatening complications.A multidisciplinary team effort and greater disease awareness are necessary to help expedite the therapeutic journey of patients with Still’s disease.7 

Join the discussion and the live Q&A led by Christopher T. Ritchlin, MD and have a conversation on the latest clinical perspectives in SpA and Still’s disease on Friday, November 6th, 6:00-8:00 PM ET.

Presented by Novartis Medical Affairs.

References

  1. Feld J, Chandran V, Haroon N, Inman R, Gladman D. Axial disease in psoriatic arthritis and ankylosing spondylitis: A critical comparison. Nat Rev Rheumatol. 2018;14(6):363-371. doi:10.1038/s41584-018-0006-8
  2. Helliwell PS. Axial disease in psoriatic arthritis. Rheumatology. 2019:1-3. doi:10.1093/rheumatology/kez629
  3. Vastert SJ, Jamilloux Y, Quartier P, et al. Anakinra in children and adults with Still’s disease. Rheumatology. 2019;58(suppl 6):vi9-vi22. doi:10.1093/rheumatology/kez350
  4. Efthimiou P. Diagnosis and management of adult onset Still’s disease. Ann Rheum Dis. 2006;65(5):564-572. doi:10.1136/ard.2005.042143
  5. Pay S, Türkçapar N, Kalyoncu M, et al. A multicenter study of patients with adult-onset Still’s disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol. 2006;25(5):639-644. doi:10.1007/s10067-005-0138-5
  6. Lenert A, Oh Gy, Ombrello MJ, Kim S. Clinical characteristics and comorbidities in adult-onset Still’s disease using a large US administrative claims database. Rheumatol (United Kingdom). 2020;59(7):1725-1733. doi:10.1093/rheumatology/kez622
  7. Pak S, Pham C. Delay in the diagnosis of adult-onset Still’s disease. Cureus. 2017;9(6). doi:10.7759/cureus.1321

10/20 M-MPD-1396919